Annual accounts receivable:
$34.37M-$4.92M(-12.53%)Summary
- As of today (September 15, 2025), AKBA annual accounts receivable is $34.37 million, with the most recent change of -$4.92 million (-12.53%) on December 31, 2024.
- During the last 3 years, AKBA annual accounts receivable has fallen by -$21.52 million (-38.51%).
- AKBA annual accounts receivable is now -38.51% below its all-time high of $55.89 million, reached on December 31, 2021.
Performance
AKBA Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$72.81M+$11.27M(+18.32%)Summary
- As of today (September 15, 2025), AKBA quarterly accounts receivable is $72.81 million, with the most recent change of +$11.27 million (+18.32%) on June 1, 2025.
- Over the past year, AKBA quarterly accounts receivable has increased by +$43.04 million (+144.61%).
- AKBA quarterly accounts receivable is now -30.93% below its all-time high of $105.42 million, reached on March 31, 2020.
Performance
AKBA Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AKBA Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.5% | +144.6% |
| 3 y3 years | -38.5% | -20.4% |
| 5 y5 years | -11.6% | +82.6% |
AKBA Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.5% | at low | -20.4% | +309.5% |
| 5 y | 5-year | -38.5% | +20.3% | -20.4% | +309.5% |
| alltime | all time | -38.5% | >+9999.0% | -30.9% | >+9999.0% |
AKBA Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $72.81M(+18.3%) |
| Mar 2025 | - | $61.54M(+79.1%) |
| Dec 2024 | $34.37M(-12.5%) | $34.37M(+6.8%) |
| Sep 2024 | - | $32.17M(+8.1%) |
| Jun 2024 | - | $29.77M(+11.8%) |
| Mar 2024 | - | $26.62M(-32.2%) |
| Dec 2023 | $39.29M(-4.3%) | $39.29M(+73.9%) |
| Sep 2023 | - | $22.59M(+15.4%) |
| Jun 2023 | - | $19.57M(+10.1%) |
| Mar 2023 | - | $17.78M(-56.7%) |
| Dec 2022 | $41.06M(-26.5%) | $41.06M(+64.5%) |
| Sep 2022 | - | $24.96M(-72.7%) |
| Jun 2022 | - | $91.42M(+33.4%) |
| Mar 2022 | - | $68.55M(+22.7%) |
| Dec 2021 | $55.89M(+95.6%) | $55.89M(+5.2%) |
| Sep 2021 | - | $53.13M(+43.9%) |
| Jun 2021 | - | $36.93M(-0.6%) |
| Mar 2021 | - | $37.15M(+30.0%) |
| Dec 2020 | $28.57M | $28.57M(+11.1%) |
| Sep 2020 | - | $25.71M(-35.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $39.87M(-62.2%) |
| Mar 2020 | - | $105.42M(+171.2%) |
| Dec 2019 | $38.86M(+133.2%) | $38.86M(+31.1%) |
| Sep 2019 | - | $29.65M(+2.7%) |
| Jun 2019 | - | $28.89M(-40.4%) |
| Mar 2019 | - | $48.44M(+190.6%) |
| Dec 2018 | $16.67M(-51.3%) | $16.67M(+2322.4%) |
| Sep 2018 | - | $688.00K(-17.3%) |
| Jun 2018 | - | $832.00K(-97.7%) |
| Mar 2018 | - | $36.31M(+6.1%) |
| Dec 2017 | $34.22M(+1.2%) | $34.22M(>+9900.0%) |
| Sep 2017 | - | $281.00K(>+9900.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $33.82M(>+9900.0%) | $33.82M(>+9900.0%) |
| Sep 2014 | - | $57.00K(-50.0%) |
| Jun 2014 | - | $114.00K(-4.5%) |
| Mar 2014 | - | $119.40K(-11.6%) |
| Dec 2013 | $135.00K(+57.7%) | $135.00K |
| Dec 2012 | $85.60K | - |
FAQ
- What is Akebia Therapeutics, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual accounts receivable year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly accounts receivable year-on-year change?
What is Akebia Therapeutics, Inc. annual accounts receivable?
The current annual accounts receivable of AKBA is $34.37M
What is the all time high annual accounts receivable for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual accounts receivable is $55.89M
What is Akebia Therapeutics, Inc. annual accounts receivable year-on-year change?
Over the past year, AKBA annual accounts receivable has changed by -$4.92M (-12.53%)
What is Akebia Therapeutics, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of AKBA is $72.81M
What is the all time high quarterly accounts receivable for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly accounts receivable is $105.42M
What is Akebia Therapeutics, Inc. quarterly accounts receivable year-on-year change?
Over the past year, AKBA quarterly accounts receivable has changed by +$43.04M (+144.61%)